Cargando…
Circulating miR-30b-5p levels in plasma as a novel potential biomarker for early detection of breast cancer
BACKGROUND: Recently, microRNAs have been demonstrated to be potential non-invasive biomarkers for diagnosis, prognosis assessment or prediction of response to treatment in cancer. In this study, we evaluate the potential of miR-30b-5p as a biomarker for early diagnosis of breast cancer (BC) in tiss...
Autores principales: | Adam-Artigues, A., Garrido-Cano, I., Simón, S., Ortega, B., Moragón, S., Lameirinhas, A., Constâncio, V., Salta, S., Burgués, O., Bermejo, B., Henrique, R., Lluch, A., Jerónimo, C., Eroles, P., Cejalvo, J.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820029/ https://www.ncbi.nlm.nih.gov/pubmed/33477007 http://dx.doi.org/10.1016/j.esmoop.2020.100039 |
Ejemplares similares
-
Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer
por: Garrido-Cano, Iris, et al.
Publicado: (2020) -
Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer
por: Adam-Artigues, Anna, et al.
Publicado: (2021) -
Delivery
of miR-200c-3p
Using Tumor-Targeted Mesoporous
Silica Nanoparticles for Breast Cancer Therapy
por: Garrido-Cano, Iris, et al.
Publicado: (2023) -
Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective
por: Hernando, Cristina, et al.
Publicado: (2021) -
miR‐99a‐5p modulates doxorubicin resistance via the COX‐2/ABCG2 axis in triple‐negative breast cancer: from the discovery to in vivo studies
por: Garrido‐Cano, Iris, et al.
Publicado: (2022)